These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 24423915)
1. [Effects of endogenous dopamine on two-state voltage oscillations of striatum medium spiny neurons]. Kong Y; Xu Z; Dong WL; Cai XY; Duan XY; Cao BY Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(43):3470-4. PubMed ID: 24423915 [TBL] [Abstract][Full Text] [Related]
2. [Electrophysiological characteristics of medium spiny neurons in neocortex-striatum-substantia nigra brain slices of rats]. Xu Z; Kong Y; Dong WL; Zhang ZC; Cao BY Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1211-4. PubMed ID: 21756778 [TBL] [Abstract][Full Text] [Related]
3. Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary? Hernández-Echeagaray E; Starling AJ; Cepeda C; Levine MS Eur J Neurosci; 2004 May; 19(9):2455-63. PubMed ID: 15128399 [TBL] [Abstract][Full Text] [Related]
4. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons. Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319 [TBL] [Abstract][Full Text] [Related]
10. Afferent influences on striatal development in organotypic cocultures. Snyder-Keller A; Tseng KY; Lyng GD; Graber DJ; O'Donnell P Synapse; 2008 Jul; 62(7):487-500. PubMed ID: 18435420 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317 [TBL] [Abstract][Full Text] [Related]
12. The PDE10A inhibitor, papaverine, differentially activates ERK in male and female rat striatal slices. Hsu YT; Liao G; Bi X; Oka T; Tamura S; Baudry M Neuropharmacology; 2011 Dec; 61(8):1275-81. PubMed ID: 21816164 [TBL] [Abstract][Full Text] [Related]
13. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron. Knoll J J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537 [TBL] [Abstract][Full Text] [Related]
14. Aberrant plasticity and "learned" motor inhibition in Parkinson's disease. Zhuang XX Sheng Li Xue Bao; 2012 Oct; 64(5):543-9. PubMed ID: 23090495 [TBL] [Abstract][Full Text] [Related]
15. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. Hossain MA; Weiner N J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556 [TBL] [Abstract][Full Text] [Related]
16. Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease. Kim W; Im MJ; Park CH; Lee CJ; Choi S; Yoon BJ Neurosci Lett; 2013 Dec; 557 Pt B():95-100. PubMed ID: 24176882 [TBL] [Abstract][Full Text] [Related]
17. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism. Warre R; Thiele S; Talwar S; Kamal M; Johnston TH; Wang S; Lam D; Lo C; Khademullah CS; Perera G; Reyes G; Sun XS; Brotchie JM; Nash JE Neurobiol Dis; 2011 Mar; 41(3):591-604. PubMed ID: 20971190 [TBL] [Abstract][Full Text] [Related]
18. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons. Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622 [TBL] [Abstract][Full Text] [Related]
19. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons. Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930 [TBL] [Abstract][Full Text] [Related]
20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]